Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
2.
Curr Res Transl Med ; 64(1): 35-42, 2016.
Article in English | MEDLINE | ID: mdl-27140597

ABSTRACT

Systemic sclerosis is an autoimmune disease characterized by sclerosis (hardening) of the skin and deep viscera associated with microvascular functional and structural alteration, which leads to chronic ischemia. In the hands of patients, ischemic and fibrotic damages lead to both pain and functional impairment. Hand disability creates a large burden in professional and daily activities, with social and psychological consequences. Currently, the proposed therapeutic options for hands rely mainly on hygienic measures, vasodilatator drugs and physiotherapy, but have many constraints and limited effects. Developing an innovative therapeutic approach is crucial to reduce symptoms and improve the quality of life. The discovery of adult stem cells from adipose tissue has increased the interest to use adipose tissue in plastic and regenerative surgery. Prepared as freshly isolated cells for immediate autologous transplantation, adipose tissue-derived stem cell therapy has emerged as a therapeutic alternative for the regeneration and repair of damaged tissues. We aim to update literature in the interest of autologous fat graft or adipose derived from stromal vascular fraction cell-based therapy for the hands of patients who suffer from systemic sclerosis.


Subject(s)
Adipose Tissue/transplantation , Adult Stem Cells/transplantation , Hand Deformities, Acquired/therapy , Mesenchymal Stem Cell Transplantation , Scleroderma, Systemic/therapy , Adult Stem Cells/metabolism , Blood Cells/transplantation , Clinical Trials as Topic , Cytokines/metabolism , Endothelial Cells/transplantation , Hand Deformities, Acquired/etiology , Humans , Injections , Intercellular Signaling Peptides and Proteins/metabolism , Lipectomy , Macrophages/transplantation , Pericytes/transplantation , Scleroderma, Systemic/complications , Stromal Cells/metabolism , Stromal Cells/transplantation , Tissue and Organ Harvesting , Transplantation, Autologous , Treatment Outcome
3.
Rev Med Interne ; 36(7): 487-90, 2015 Jul.
Article in French | MEDLINE | ID: mdl-25172778

ABSTRACT

INTRODUCTION: Malignant thymoma or thymic hyperplasia is associated with various autoimmune diseases. Renal disease has rarely been reported in this condition. We report a new case with improvement of renal disease after thymectomy. CASE REPORT: A 77-year-old-women with nephritic syndrome was found to have associated thymic mass. Renal pathology showed membranous nephropathy. The thymic mass pathology showed a B2 type thymoma. After thymectomy the nephrotic syndrome improved. CONCLUSION: Glomerulopathy can be secondary to an acquired thymic disease. Membranous nephropathy but also other glomerular diseases can be observed often presenting with nephritic syndrome. Despite the rarity of this association this clinical observation underlines that a thymoma should be searched in the presence of a glomerulopathy. The glomerulopathy can be improved by the treatment of the thymoma.


Subject(s)
Glomerulonephritis, Membranous/complications , Kidney/pathology , Nephrotic Syndrome/complications , Thymoma/complications , Thymus Neoplasms/complications , Aged , Female , Humans , Thymectomy , Thymoma/surgery , Thymus Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...